Related Experiment Video
Updated: Jan 11, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Caffeine Protects Newborn Rat Lungs Against the Effects of Hyperoxia and Intra-Amniotic Enterotoxin
Victoria Mielgo1, Chiara Catozzi2, Francesca Ricci2
1Animal Research Unit, Biocruces-Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.
Insights
Caffeine treatment improved lung function and structure in rat models of bronchopulmonary dysplasia (BPD) caused by prenatal or postnatal factors. This suggests caffeine may be an effective strategy for BPD prevention.
Area of Science:
- Neonatal Medicine
- Pulmonary Medicine
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a complex lung disease in neonates with multifactorial causes.
- Current treatments for BPD lack complete effectiveness in prevention or management.
- Prenatal and postnatal factors significantly contribute to BPD pathogenesis.
Purpose of the Study:
- To investigate the therapeutic effects of caffeine in rat models of BPD.
- To evaluate caffeine's efficacy in models induced by both prenatal and postnatal factors.
- To assess caffeine's impact on lung function, structure, and pulmonary hypertension.
Main Methods:
- Two BPD-like rat models were established: one using prenatal endotoxin (ETX) and another using postnatal hyperoxia (HYP).
- Caffeine (20 mg/kg) was administered every other day until postnatal day 14 in both models.
- Lung function, lung structure, and pulmonary hypertension were assessed on postnatal day 14.
Main Results:
- Untreated rats in both BPD models exhibited impaired lung function, structure, and developed pulmonary hypertension.
- Caffeine administration significantly improved lung compliance and alveolarization.
- Caffeine treatment also enhanced lung vascular growth and reduced pulmonary hypertension.
Conclusions:
- Caffeine administration preserved lung function and structure in prenatal and postnatal BPD-like models.
- Caffeine effectively prevented pulmonary hypertension in the studied rat models.
- Caffeine shows promise as an effective preventative strategy for BPD, especially when prenatal or postnatal factors are implicated.
Introduction:
Bronchopulmonary dysplasia (BPD) has a multifactorial etiology with prenatal and/or postnatal factors contributing to the pathogenesis, and there is no completely effective treatment to prevent or treat this condition. Our objective was to evaluate the effects of caffeine treatment in two BPD-like rat models using prenatal and postnatal factors.
Methods:
In a BPD-like model induced by a prenatal factor, endotoxin (ETX) or saline was administered to pregnant rats by intra-amniotic (i.a.) injection on day 20 of pregnancy, and pups were delivered by cesarean section at term (day 22). On the other hand, for a BPD-like model induced by a postnatal factor, the pups were maintained in hyperoxia (80%-85%) (HYP) or normoxia (room air) for 14 days after natural birth. In both models, caffeine (20 mg/kg) was administered every other day until postnatal day 14. On postnatal day 14, we assessed lung function (peak-inspiratory-pressure, compliance), lung structure (radial-alveolar-count, mean-linear-intercept, pulmonary-vessel-density), and pulmonary hypertension.
Result:
The effects of i.a. ETX or HYP were evident in neonatal rats not receiving treatment, these animals showing impaired lung function and lung structure and developing pulmonary hypertension compared to results after i.a. saline administration or normoxia. Postnatal caffeine administration was associated with significantly better outcomes in terms of lung compliance, alveolarization, lung vascular growth, and pulmonary hypertension.
Conclusion:
In a BPD-like model induced by prenatal (i.a. ETX) or postnatal (HYP) factors, caffeine administration preserved lung function and structure and prevented pulmonary hypertension. These findings confirm that caffeine (the drug most commonly prescribed in neonatal care units) may provide an effective strategy for BPD prevention when prenatal or postnatal factors are involved.
